immune globulin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for immune globulin, covering 2018-09-07 to 2018-09-07. Get the full timeline:
Most recent: Clinical Trial Update: Use of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney Transplantation [Phase 1, Phase 2]